Arkolith/Insider Trading/EDGE

EDGE Insider Trading

Edge Therapeutics, Inc. · full profile →Last filing Jan 12, 2026

Edge Therapeutics, Inc. also files under PDSB; those filings are included.

Mixed · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$0
open market, 180d
Reporting Insiders
0
0 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

100 shown
DateInsiderRoleActionSharesPriceValue
Jan 12, 2026Brawley Otis WDirectorGrant(A)55K—$0
Jan 12, 2026Glover Stephen C.DirectorGrant(A)55K—$0
Jan 12, 2026Boesgaard LarsChief Financial OfficerGrant(A)300K—$0
Jan 12, 2026Ali-Jackson KamilDirectorGrant(A)55K—$0
Jan 12, 2026Shepard Kirk V.Chief Medical OfficerGrant(A)300K—$0
Jan 12, 2026Freitag Gregory GeneDirectorGrant(A)55K—$0
Jan 12, 2026Brown Spencer D.Senior VP, General CounselGrant(A)300K—$0
Jan 12, 2026Toutain StephanChief Operating OfficerGrant(A)300K—$0
Jan 12, 2026Bedu-Addo FrankPresident/CEO, DirectorGrant(A)549K—$0
Jan 12, 2026Iliev IlianDirectorGrant(A)55K—$0
Jan 12, 2026Conn GregoryChief Scientific OfficerGrant(A)150K—$0
Jun 12, 2025Boesgaard LarsChief Financial OfficerGrant(A)150K—$0
Jun 12, 2025Toutain StephanChief Operations OfficerGrant(A)150K—$0
Jun 12, 2025Shepard Kirk V.Chief Medical OfficerGrant(A)150K—$0
Jun 12, 2025Brown Spencer D.Senior VP, General CounselGrant(A)150K—$0
Jun 12, 2025Conn GregoryChief Scientific OfficerGrant(A)40K—$0
Jun 12, 2025Bedu-Addo FrankPresident/CEO, DirectorGrant(A)150K—$0
Jun 11, 2025Brawley Otis WDirectorGrant(A)23K—$0
Jun 11, 2025Iliev IlianDirectorGrant(A)23K—$0
Jun 11, 2025Ali-Jackson KamilDirectorGrant(A)23K—$0
Jun 11, 2025Freitag Gregory GeneDirectorGrant(A)23K—$0
Jun 11, 2025Glover Stephen C.DirectorGrant(A)23K—$0
Feb 28, 2025Freitag Gregory GeneDirectorBuy(P)15K$1.66$25K
Feb 28, 2025Glover Stephen C.DirectorBuy(P)15K$1.66$25K
Feb 28, 2025Freitag Gregory GeneDirectorBuy(P)15K——
Feb 28, 2025Glover Stephen C.DirectorBuy(P)15K——
Jun 24, 2024Ali-Jackson KamilDirectorGrant(A)9K—$0
Jun 24, 2024Freitag Gregory GeneDirectorGrant(A)9K—$0
Jun 24, 2024Sykes RichardDirectorGrant(A)9K—$0
Jun 24, 2024Glover Stephen C.DirectorGrant(A)9K—$0
Jun 24, 2024Brawley Otis WDirectorGrant(A)9K—$0
Jun 24, 2024Iliev IlianDirectorGrant(A)9K—$0
May 1, 2024Toutain StephanChief Operations OfficerGrant(A)200K—$0
Feb 28, 2024Bedu-Addo FrankPresident/CEO, DirectorGrant(A)300K—$0
Feb 28, 2024Brown Spencer D.Senior VP, General CounselGrant(A)56K—$0
Feb 28, 2024Conn GregoryChief Scientific OfficerGrant(A)47K—$0
Jan 22, 2024Shepard Kirk V.Chief Medical OfficerGrant(A)200K—$0
Dec 4, 2023Boesgaard LarsChief Financial OfficerGrant(A)200K—$0
Jul 14, 2023Sykes RichardDirectorGrant(A)9K—$0
Jul 14, 2023Glover Stephen C.DirectorGrant(A)9K—$0
Jul 14, 2023Freitag Gregory GeneDirectorGrant(A)9K—$0
Jul 14, 2023Iliev IlianDirectorGrant(A)9K—$0
Jul 14, 2023Ali-Jackson KamilDirectorGrant(A)9K—$0
Jul 14, 2023Brawley Otis WDirectorGrant(A)9K—$0
Jan 5, 2023Wood LaurenChief Medical OfficerGrant(A)111K—$0
Jan 5, 2023Brown Spencer D.Senior VP, General CounselGrant(A)20K—$0
Jan 5, 2023Hill Matthew CChief Financial OfficerGrant(A)161K—$0
Jan 5, 2023Conn GregoryChief Scientific OfficerGrant(A)137K—$0
Jan 5, 2023Bedu-Addo FrankPresident/CEO, DirectorGrant(A)385K—$0
Dec 2, 2022Bedu-Addo FrankPresident/CEO, DirectorOption exercise(M)220K—$0
Dec 2, 2022Bedu-Addo FrankPresident/CEO, DirectorOption exercise(M)220K$6.57$1.4M
Dec 2, 2022Bedu-Addo FrankPresident/CEO, DirectorTax withholding(F)175K$9.78$1.7M
Jun 28, 2022Freitag Gregory GeneDirectorGrant(A)9K—$0
Jun 28, 2022Sykes RichardDirectorGrant(A)9K—$0
Jun 28, 2022Glover Steve CDirectorGrant(A)9K—$0
Jun 28, 2022Iliev IlianDirectorGrant(A)9K—$0
Jun 28, 2022Brawley Otis WDirectorGrant(A)9K—$0
Jun 28, 2022Ali-Jackson KamilDirectorGrant(A)9K—$0
Jun 2, 2022Brown Spencer D.Senior VP, General CounselGrant(A)150K—$0
Jan 19, 2022Conn GregoryChief Scientific OfficerGrant(A)112K—$0
Jan 19, 2022Bedu-Addo FrankPresident/CEO, DirectorGrant(A)292K—$0
Jan 19, 2022Wood LaurenChief Medical OfficerGrant(A)89K—$0
Dec 13, 2021Hill Matthew CChief Financial OfficerBuy(P)400$8.90$4K
Dec 13, 2021Hill Matthew CChief Financial OfficerBuy(P)3K$9.00$23K
Dec 13, 2021Hill Matthew CChief Financial OfficerBuy(P)100$9.00$900
Dec 13, 2021Hill Matthew CChief Financial OfficerBuy(P)100$9.00$900
Oct 19, 2021Hill Matthew CChief Financial OfficerGrant(A)203K—$0
Jun 17, 2021Glover Steve CDirectorGrant(A)9K—$0
Jun 17, 2021Brawley Otis WDirectorGrant(A)9K—$0
Jun 17, 2021Ali-Jackson KamilDirectorGrant(A)9K—$0
Jun 17, 2021Sykes RichardDirectorGrant(A)9K—$0
Jun 17, 2021Freitag Gregory GeneDirectorGrant(A)9K—$0
Jun 17, 2021Iliev IlianDirectorGrant(A)9K—$0
Jun 16, 2021Bloomquist DeLyle WInsiderBuy(P)10K$9.88$99K
Jun 16, 2021Bloomquist DeLyle WInsiderOption exercise(M)3K—$0
Jun 16, 2021Bloomquist DeLyle WInsiderOption exercise(M)3K$5.99$18K
Jun 15, 2021Van Voorhees SethChief Financial OfficerBuy(P)18K$8.50$150K
Jun 15, 2021Freitag Gregory GeneDirectorBuy(P)6K$8.50$50K
Jun 15, 2021Bedu-Addo FrankPresident/CEO, DirectorOption exercise(M)53K—$0
Jun 15, 2021Bedu-Addo FrankPresident/CEO, DirectorOption exercise(M)53K$6.57$349K
Jun 15, 2021Bedu-Addo FrankPresident/CEO, DirectorTax withholding(F)27K$12.86$349K
Jun 15, 2021Glover Steve CDirectorBuy(P)6K$8.50$50K
Jun 15, 2021Ali-Jackson KamilDirectorBuy(P)12K$8.50$100K
Jan 4, 2021Van Voorhees SethChief Financial OfficerGrant(A)203K—$0
Dec 8, 2020Bedu-Addo FrankPresident/CEO, DirectorGrant(A)708K—$0
Dec 8, 2020Conn GregoryChief Scientific OfficerGrant(A)122K—$0
Dec 8, 2020Wood LaurenChief Medical OfficerGrant(A)211K—$0
Dec 8, 2020King Michael N.Interim CFOGrant(A)50K—$0
Nov 3, 2020Brawley Otis WDirectorGrant(A)9K—$0
Jun 23, 2020Freitag Gregory GeneDirectorGrant(A)9K—$0
Jun 23, 2020Glover Steve CDirectorGrant(A)9K—$0
Jun 23, 2020Sykes RichardDirectorGrant(A)9K—$0
Jun 23, 2020Ali-Jackson KamilDirectorGrant(A)3K—$0
Jun 23, 2020Wood LaurenChief Medical OfficerGrant(A)35K—$0
Jun 23, 2020Bloomquist DeLyle WDirectorGrant(A)9K—$0
Jun 23, 2020Iliev IlianDirectorGrant(A)2K—$0
Jun 23, 2020Conn GregoryChief Scientific OfficerGrant(A)35K—$0
Jun 23, 2020Bedu-Addo FrankPresident/CEO, DirectorGrant(A)125K—$0
Apr 8, 2020Iliev IlianDirectorGrant(A)5K—$0
Feb 21, 2020Ali-Jackson KamilDirectorGrant(A)9K—$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Issuer: Edge Therapeutics, Inc., SEC CIK 0001472091. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under EDGE and shows every filing by that issuer (also filed as PDSB).

Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-09. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).

Keep exploring

Connected pages for EDGE